Tenormin
Tenormin Price range: $ 78,00 through $ 580,00
Back to products
Tentex Forte
Tentex Forte Original price was: $ 57,00.Current price is: $ 56,00.

Tenovate

Price range: $ 30,00 through $ 102,00

Tenovate is a highly potent topical corticosteroid designed to effectively manage various inflammatory skin conditions. It is primarily used to provide relief from the redness, swelling, and itching associated with moderate to severe eczema and psoriasis. The active ingredient works by suppressing the immune response in the affected area to reduce inflammation and promote skin healing. This medication is also effective in treating stubborn dermatoses such as lichen planus and discoid lupus erythematosus. Regular application helps restore the skin’s healthy appearance and significantly improves overall comfort for those dealing with chronic skin irritation.

Active substance: Clobetasol Propionate
SKU: Tenovate Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Tenovate (clobetasol propionate) belongs to the class of super-high potency topical corticosteroids prescribed for severe inflammatory dermatoses. It is formulated to relieve the inflammatory and pruritic manifestations of corticosteroid-responsive skin disorders, including recalcitrant eczema and severe plaque psoriasis.

Due to its exceptionally high biological potency, this prescription medication requires strict adherence to medical guidance. Warning: misuse or prolonged application can lead to serious local and systemic adverse effects, including hypothalamic-pituitary-adrenal (HPA) axis suppression.

Basic Information Overview

Parameter Clinical Details
Active ingredient (INN) Clobetasol propionate (0.05%)
Therapeutic class Super-high potency topical corticosteroid (Class 1)
Dosage form Topical cream / ointment / solution
Route of administration Topical (cutaneous application)
Prescription status Prescription only (Rx)
Primary purpose Short-term relief of severe inflammatory skin conditions

Important Precautions

Warning: Tenovate carries significant risks if improperly used. Systemic absorption of topical clobetasol propionate can produce reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients. Conditions that increase systemic absorption include the application of high-potency steroids over large surface areas, prolonged use, and the use of occlusive dressings.

Patients applying a topical steroid to a large surface area or to areas under occlusion must be evaluated periodically for evidence of HPA axis suppression using specific diagnostic tests, such as the morning plasma cortisol or ACTH stimulation test. Pediatric populations are at a higher risk of systemic toxicity and HPA axis suppression due to a larger skin surface area-to-body mass ratio. Never use this medication on pediatric patients without explicit instruction and monitoring from a pediatric specialist.

Main Uses

Tenovate is indicated for the short-term relief of severe inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Clinical indications include severe plaque psoriasis, recalcitrant eczema, lichen planus, and resistant cases of dermatitis that have failed to respond adequately to lower-potency topical corticosteroids.

This medication is not indicated for mild skin conditions, facial rash, acne vulgaris, rosacea, or perioral dermatitis. It must never be applied to fungal, viral, or bacterial skin infections, as corticosteroid treatment suppresses immune responses and may allow underlying cutaneous infections to rapidly worsen.

How the Drug Works

Clobetasol propionate is a corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. At the cellular level, corticosteroids act by binding to cytoplasmic glucocorticoid receptors. This complex translocates to the cell nucleus, regulating gene expression and modulating the synthesis of specific inflammatory mediators.

Specifically, clobetasol induces lipocortins (phospholipase A2 inhibitory proteins), which inhibit the release of arachidonic acid. By preventing arachidonic acid release, the medication suppresses the downstream synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. This biochemical cascade rapidly decreases capillary permeability, erythema, edema, and itching in affected skin tissue.

Dosing Schedule

Strict Dosage Limits: Apply a thin film of Tenovate to the affected skin areas twice daily and rub in gently and completely. The dose should be limited to the minimal amount necessary to achieve therapeutic control.

Treatment should be restricted to a maximum of 2 consecutive weeks. The total dose must not exceed 50 g per week (or 50 mL per week for solution formulations) due to the risk of suppressing the HPA axis. Do not cover, bandage, or wrap the treated skin area unless directed to do so by a physician. Occlusion dramatically increases cutaneous penetration and systemic absorption, elevating the risk of localized skin atrophy and systemic corticosteroid toxicity.

What Happens in the Body

The extent of percutaneous absorption of clobetasol propionate is determined by several factors, including the vehicle, the integrity of the epidermal barrier, and the presence of inflammation or occlusive dressings. Intact skin generally absorbs minor quantities, but damaged epidermal barriers or inflamed skin allow significantly higher drug penetration.

Once absorbed through the skin, topical corticosteroids follow pharmacokinetic pathways similar to systemically administered corticosteroids. Clobetasol propionate is bound to plasma proteins in varying degrees, metabolized primarily by the liver, and excreted predominantly by the kidneys, with a portion excreted in the bile.

Adverse Reactions

Local side effects are relatively common, particularly with prolonged use or improper application. These include cutaneous burning, stinging, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, and skin maceration.

Continuous treatment can cause irreversible local skin changes, including cutaneous atrophy, striae (stretch marks), and telangiectasia (visible blood vessels). Systemic adverse reactions–such as adrenal suppression, Cushingoid features, weight gain, hypertension, and elevation of blood glucose–may occur if excessive amounts are absorbed over extended periods.

What Not to Combine

Concurrent use of other topical or systemic corticosteroids should be avoided, as this significantly escalates the risk of systemic corticosteroid accumulation and HPA axis suppression. Combining Tenovate with topical agents containing alcohol or irritating peeling agents can amplify skin irritation and localized breakdown.

Although systemic interactions are rare with appropriate topical use, strong CYP3A4 inhibitors (such as ritonavir, ketoconazole, or itraconazole) can inhibit the metabolism of any absorbed clobetasol propionate. This metabolic inhibition increases systemic corticosteroid exposure, heightening the potential for adrenal insufficiency and systemic toxicity.

Red Flags

Certain symptoms mandate immediate discontinuation of the drug and emergency medical assessment. Patients must remain vigilant for systemic side effects or hypersensitivity reactions.

Warning Sign Immediate Risk Required Action
Swelling of face, lips, tongue, or throat Anaphylaxis / Severe allergic reaction Seek emergency medical care immediately
Severe dizziness, extreme fatigue, fainting Systemic HPA axis / Adrenal suppression Contact physician and seek immediate evaluation
Pus formation, severe redness, spreading warmth Secondary cutaneous bacterial/fungal infection Discontinue use and consult a physician
Skin thinning, severe bruising, deep striae Irreversible dermal atrophy Stop application and seek dermatological review

If You Skip a Dose

If a scheduled application is missed, apply the thin layer of medication as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule.

Warning: Never apply double amounts or apply the medication more frequently to compensate for a missed dose. Over-application increases cutaneous saturation and accelerates systemic absorption without providing additional therapeutic benefit.

Day-to-Day Use

Always wash hands thoroughly with soap and water before and after applying Tenovate, unless hands are the targeted area of treatment. Clean and dry the affected area gently before applying a small, thin layer of medication.

Avoid contact with eyes, eyelids, mouth, and internal mucous membranes. If accidental contact with eyes occurs, flush immediately with large volumes of cold water. Do not use this high-potency medication on facial, groin, or axillary (underarm) areas unless explicitly instructed by a dermatologist, as these anatomical regions are highly prone to rapid skin atrophy.

Storage and Expiration

Store Tenovate at controlled room temperature between 20°C to 25°C (68°F to 77°F). Brief exposure to temperatures ranging from 15°C to 30°C (59°F to 86°F) is permitted. Keep the container tightly closed when not in use.

Do not freeze or store in high-humidity environments such as bathrooms. Protect from excessive heat and direct sunlight. Keep out of reach of children and pets. Properly discard any unused medication past its printed expiration date.

Common Questions

How long can Tenovate be safely applied without a break?

Tenovate should strictly be used for a maximum of 2 consecutive weeks. Due to its super-high potency, prolonged continuous application dramatically elevates the risk of severe skin atrophy and systemically induced adrenal suppression. If symptoms do not improve within 2 weeks, a complete re-evaluation by your healthcare provider is required.

Can Tenovate be used on facial skin or sensitive areas?

No, application to the face, groin, or axillae (underarms) is generally avoided. Facial and intertriginous skin is thinner and substantially more susceptible to rapid skin breakdown, permanent striae, telangiectasia, and accelerated drug absorption. Only use on these sensitive sites if explicitly prescribed and monitored by your dermatologist.

What should happen if a skin infection develops during treatment?

If a secondary bacterial, fungal, or viral skin infection develops or worsens during treatment, topically applied steroids should be discontinued immediately. Corticosteroids suppress localized immune responses and can allow infections to spread. Your physician will prescribe an appropriate antimicrobial therapy before considering further steroid use.

Why is covering the treated skin with a bandage strictly discouraged?

Covering treated skin with occlusive materials (such as plastic wrap, tight bandages, or waterproof dressings) significantly increases temperature and skin hydration. This dramatically increases the rate of clobetasol absorption into the bloodstream, multiplying the likelihood of systemic side effects, hypothalamic-pituitary-adrenal suppression, and skin damage.

Can Tenovate lead to systemic hormonal imbalances?

Yes. Although applied topically, significant absorption of clobetasol propionate can temporarily suppress the body’s natural cortisol production by affecting the hypothalamic-pituitary-adrenal (HPA) axis. Abrupt discontinuation after extensive use can cause signs of adrenal insufficiency, including extreme tiredness, low blood pressure, and severe weakness.

In accordance with FDA requirements.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

15g

,

30 gm

Package

3 tubes

,

4 tubes

,

5 tubes

,

6 tubes

,

7 tubes

,

8 tubes

,

9 tubes

,

10 tubes

,

12 tubes

Ενεργός Ουσία